These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6836326)

  • 1. Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide.
    Gurtoo HL; Marinello AJ; Berrigan MJ; Bansal SK; Paul B; Pavelic ZP; Struck RF
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):35-45. PubMed ID: 6836326
    [No Abstract]   [Full Text] [Related]  

  • 2. Denaturation of cytochrome P-450 by cyclophosphamide metabolites.
    Marinello AJ; Gurtoo HL; Struck RF; Paul B
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1347-53. PubMed ID: 697865
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of thiols in cyclophosphamide-induced urotoxicity and depression of hepatic drug metabolism.
    Berrigan MJ; Marinello AJ; Pavelic Z; Williams CJ; Struck RF; Gurtoo HL
    Cancer Res; 1982 Sep; 42(9):3688-95. PubMed ID: 6809312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection by N-acetylcysteine of cyclophosphamide metabolism - related in vivo depression of mixed function oxygenase activity and in vitro denaturation of cytochrome P-450.
    Berrigan MJ; Gurtoo HL; Sharma SD; Struck RF; Marinello AJ
    Biochem Biophys Res Commun; 1980 Apr; 93(3):797-803. PubMed ID: 7387676
    [No Abstract]   [Full Text] [Related]  

  • 7. Formation, toxicity and inactivation of acrolein during biotransformation of cyclophosphamide as studied in freshly isolated cells from rat liver and kidney.
    Ohno Y; Ormstad K
    Arch Toxicol; 1985 Jun; 57(2):99-103. PubMed ID: 4026579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprotection against cyclophosphamide-induced urotoxicity: comparison of nine thiol protective agents.
    Roberts JC; Francetic DJ; Zera RT
    Anticancer Res; 1994; 14(2A):389-95. PubMed ID: 8017838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of indomethacin, aspirin, nordihydroguairetic acid, and piperonyl butoxide on cyclophosphamide-induced bladder damage.
    Frasier L; Kehrer JP
    Drug Chem Toxicol; 1993; 16(2):117-33. PubMed ID: 8486095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of metabolites of cyclophosphamide in cardiotoxicity.
    Kurauchi K; Nishikawa T; Miyahara E; Okamoto Y; Kawano Y
    BMC Res Notes; 2017 Aug; 10(1):406. PubMed ID: 28807058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.
    Hales BF
    Cancer Res; 1982 Aug; 42(8):3016-21. PubMed ID: 7046914
    [No Abstract]   [Full Text] [Related]  

  • 12. Role of acrolein in cyclophosphamide teratogenicity in rat embryos in vitro.
    Mirkes PE; Greenaway JC; Rogers JG; Brundrett RB
    Toxicol Appl Pharmacol; 1984 Feb; 72(2):281-91. PubMed ID: 6546458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the induction of hepatic microsomal metabolism on the toxicity of cyclophosphamide.
    Gurtoo HL; Bansal SK; Pavelic Z; Struck RF
    Br J Cancer; 1985 Jan; 51(1):67-75. PubMed ID: 3966972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.
    Gurtoo HL; Marinello AJ; Struck RF; Paul B; Dahms RP
    J Biol Chem; 1981 Nov; 256(22):11691-701. PubMed ID: 7298626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of in vivo and in vitro murine immune responses by the cyclophosphamide metabolite acrolein.
    Kawabata TT; White KL
    Cancer Res; 1988 Jan; 48(1):41-5. PubMed ID: 3257162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of diuretics on urinary general base catalytic activity and cyclophosphamide-induced bladder toxicity.
    Sladek NE; Smith PC; Bratt PM; Low JE; Powers JF; Borch RF; Coveney JR
    Cancer Treat Rep; 1982 Nov; 66(11):1889-1900. PubMed ID: 7139634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of reactive metabolites in drug-induced teratogenesis.
    Hales BF; Slott VL
    Prog Clin Biol Res; 1987; 253():181-91. PubMed ID: 3432286
    [No Abstract]   [Full Text] [Related]  

  • 19. Competitive inhibition of human liver microsomal cytochrome P450 3A-dependent steroid 6 beta-hydroxylation activity by cyclophosphamide and ifosfamide in vitro.
    Murray M; Butler AM; Stupans I
    J Pharmacol Exp Ther; 1994 Aug; 270(2):645-9. PubMed ID: 8071856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two cytotoxicity assays for the detection of metabolism-mediated toxicity in vitro: a study with cyclophosphamide.
    Horner SA; Fry JR; Clothier RH; Balls M
    Xenobiotica; 1985; 15(8-9):681-6. PubMed ID: 3878046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.